We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current INSM market cap is 3.83B. The company's latest EPS is USD -5.0479 and P/E is -5.11.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 62.49M | 61.1M | 74.71M | 77.23M | 79.07M |
| Operating Income | -127.7M | -151.48M | -148.16M | -226.03M | -147.67M |
| Net Income | -131.15M | -160.12M | -159.76M | -244.81M | -158.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 136.47M | 164.41M | 188.46M | 266.16M | 305.21M |
| Operating Income | -235.25M | -265.23M | -375.09M | -457.32M | -709.63M |
| Net Income | -254.34M | -294.09M | -434.65M | -481.53M | -749.57M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 994.82M | 1.66B | 1.52B | 1.44B | 1.32B |
| Total Liabilities | 1.02B | 1.57B | 1.56B | 1.59B | 1.61B |
| Total Equity | -29.96M | 87.95M | -44.65M | -155.75M | -289.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 742.3M | 796.16M | 1.24B | 1.66B | 1.33B |
| Total Liabilities | 480.63M | 520.27M | 833.04M | 1.57B | 1.66B |
| Total Equity | 261.67M | 275.88M | 410.47M | 87.95M | -331.92M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -297.29M | -400.44M | -146.3M | -269.1M | -405.43M |
| Investing | -54.89M | -34.58M | 41.6M | -232.55M | -225.41M |
| Financing | 49.89M | 793.27M | -399k | 43.93M | 45.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -250.65M | -219.35M | -363.3M | -400.44M | -536.25M |
| Investing | -42.27M | -6.82M | -64.29M | -34.58M | -223.6M |
| Financing | 285.28M | 271M | 612.55M | 793.27M | 168.44M |
| Market Cap | 3.83B |
| Price to Earnings Ratio | -5.11 |
| Price to Sales Ratio | 12.54 |
| Price to Cash Ratio | 7.94 |
| Price to Book Ratio | -11.53 |
| Dividend Yield | - |
| Shares Outstanding | 148.49M |
| Average Volume (1 week) | 2.89M |
| Average Volume (1 Month) | 2.08M |
| 52 Week Change | 40.96% |
| 52 Week High | 32.00 |
| 52 Week Low | 17.411 |
| Spread (Intraday) | 1.74 (6.64%) |
| Company Name | Insmed Inc |
| Address |
10 finderne avenue bridgewater, new jersey 08807 |
| Website | https://www.insmed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
